ID   UD16_HUMAN              Reviewed;         532 AA.
AC   P19224; A6NKK6; B8K289; Q96TE7;
DT   01-NOV-1990, integrated into UniProtKB/Swiss-Prot.
DT   11-APR-2003, sequence version 2.
DT   10-MAY-2017, entry version 165.
DE   RecName: Full=UDP-glucuronosyltransferase 1-6;
DE            Short=UDPGT 1-6;
DE            Short=UGT1*6;
DE            Short=UGT1-06;
DE            Short=UGT1.6;
DE            EC=2.4.1.17;
DE   AltName: Full=Phenol-metabolizing UDP-glucuronosyltransferase;
DE   AltName: Full=UDP-glucuronosyltransferase 1-F;
DE            Short=UGT-1F;
DE            Short=UGT1F;
DE   AltName: Full=UDP-glucuronosyltransferase 1A6;
DE   Flags: Precursor;
GN   Name=UGT1A6; Synonyms=GNT1, UGT1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], TISSUE SPECIFICITY, AND VARIANTS
RP   TYR-70 AND PRO-510.
RX   PubMed=1339448;
RA   Ritter J.K., Chen F., Sheen Y.Y., Tran H.M., Kimura S., Yeatman M.T.,
RA   Owens I.S.;
RT   "A novel complex locus UGT1 encodes human bilirubin, phenol, and other
RT   UDP-glucuronosyltransferase isozymes with identical carboxyl
RT   termini.";
RL   J. Biol. Chem. 267:3257-3261(1992).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA].
RX   PubMed=3141926; DOI=10.1073/pnas.85.22.8381;
RA   Harding D., Fournel-Gigleux S., Jackson M.R., Burchell B.;
RT   "Cloning and substrate specificity of a human phenol UDP-
RT   glucuronosyltransferase expressed in COS-7 cells.";
RL   Proc. Natl. Acad. Sci. U.S.A. 85:8381-8385(1988).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=11434514; DOI=10.1097/00008571-200106000-00011;
RA   Gong Q.H., Cho J.W., Huang T., Potter C., Gholami N., Basu N.K.,
RA   Kubota S., Carvalho S., Pennington M.W., Owens I.S., Popescu N.C.;
RT   "Thirteen UDP-glucuronosyltransferase genes are encoded at the human
RT   UGT1 gene complex locus.";
RL   Pharmacogenetics 11:357-368(2001).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3), AND VARIANTS ALA-181 AND
RP   SER-184.
RA   Guillemette C., Levesque E., Girard H., Bernard O.;
RL   Submitted (JAN-2006) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1-488 (ISOFORM 2).
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-33.
RX   PubMed=9466822; DOI=10.1006/abbi.1997.0485;
RA   Muenzel P.A., Lehmkoester T., Brueck M., Ritter J.K., Bock K.W.;
RT   "Aryl hydrocarbon receptor-inducible or constitutive expression of
RT   human UDP glucuronosyltransferase UGT1A6.";
RL   Arch. Biochem. Biophys. 350:72-78(1998).
RN   [8]
RP   ALTERNATIVE SPLICING, AND TISSUE SPECIFICITY.
RX   PubMed=18004212; DOI=10.1097/FPC.0b013e3282f1f118;
RA   Girard H., Levesque E., Bellemare J., Journault K., Caillier B.,
RA   Guillemette C.;
RT   "Genetic diversity at the UGT1 locus is amplified by a novel 3'
RT   alternative splicing mechanism leading to nine additional UGT1A
RT   proteins that act as regulators of glucuronidation activity.";
RL   Pharmacogenet. Genomics 17:1077-1089(2007).
RN   [9]
RP   SUBUNIT.
RX   PubMed=20610558; DOI=10.1124/dmd.110.034835;
RA   Bellemare J., Rouleau M., Girard H., Harvey M., Guillemette C.;
RT   "Alternatively spliced products of the UGT1A gene interact with the
RT   enzymatically active proteins to inhibit glucuronosyltransferase
RT   activity in vitro.";
RL   Drug Metab. Dispos. 38:1785-1789(2010).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [11]
RP   VARIANTS ALA-181 AND SER-184.
RX   PubMed=9429234;
RA   Ciotti M., Marrone A., Potter C., Owens I.S.;
RT   "Genetic polymorphism in the human UGT1A6 (planar phenol) UDP-
RT   glucuronosyltransferase: pharmacological implications.";
RL   Pharmacogenetics 7:485-495(1997).
RN   [12]
RP   VARIANTS ALA-7; ALA-181 AND SER-184.
RX   PubMed=15284531; DOI=10.1097/01.fpc.0000114771.78957.cb;
RA   Nagar S., Zalatoris J.J., Blanchard R.L.;
RT   "Human UGT1A6 pharmacogenetics: identification of a novel SNP,
RT   characterization of allele frequencies and functional analysis of
RT   recombinant allozymes in human liver tissue and in cultured cells.";
RL   Pharmacogenetics 14:487-499(2004).
RN   [13]
RP   VARIANTS ALA-181 AND SER-184.
RX   PubMed=19204906; DOI=10.1002/humu.20946;
RA   Menard V., Girard H., Harvey M., Perusse L., Guillemette C.;
RT   "Analysis of inherited genetic variations at the UGT1 locus in the
RT   French-Canadian population.";
RL   Hum. Mutat. 30:677-687(2009).
CC   -!- FUNCTION: UDPGT is of major importance in the conjugation and
CC       subsequent elimination of potentially toxic xenobiotics and
CC       endogenous compounds. This isoform has specificity for phenols.
CC       Isoform 3 lacks transferase activity but acts as a negative
CC       regulator of isoform 1 (By similarity). {ECO:0000250}.
CC   -!- CATALYTIC ACTIVITY: UDP-glucuronate + acceptor = UDP + acceptor
CC       beta-D-glucuronoside.
CC   -!- SUBUNIT: Isoform 1 interacts with isoform 3/i2 suggesting that
CC       oligomerization is involved in negative regulation of transferase
CC       activity by isoform 3. Isoform 1 also interacts with respective i2
CC       isoforms of UGT1A1, UGT1A3, UGT1A4, UGT1A7, UGT1A8, UGT1A9 and
CC       UGT1A10. {ECO:0000269|PubMed:20610558}.
CC   -!- SUBCELLULAR LOCATION: Microsome. Endoplasmic reticulum membrane
CC       {ECO:0000305}; Single-pass membrane protein {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1; Synonyms=i1;
CC         IsoId=P19224-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P19224-2; Sequence=VSP_045779;
CC         Note=No experimental confirmation available.;
CC       Name=3; Synonyms=i2, UGT1A6s;
CC         IsoId=P19224-3; Sequence=VSP_053962;
CC   -!- TISSUE SPECIFICITY: Expressed in skin. Isoforms 1 and 3 are
CC       expressed in kidney and liver. Isoform 1 but not isoform 2 is
CC       expressed in colon, esophagus and small intestine.
CC       {ECO:0000269|PubMed:1339448, ECO:0000269|PubMed:18004212}.
CC   -!- POLYMORPHISM: Polymorphisms in the UGT1A6 gene define four common
CC       haplotypes: UGT1A6*1, UGT1A6*2, UGT1A6*3 and UGT1A6*4. Liver
CC       tissue samples that were homozygous for UGT1A6*2 exhibited a high
CC       rate of glucuronidation relative to tissues with other genotypes.
CC       Biochemical kinetic studies indicate that the UGT1A6*2 allozyme,
CC       expressed homozygously, had almost two-fold greater activity
CC       toward p-nitrophenol than UGT1A6*1 and when expressed
CC       heterozygously (UGT1A6*1/*2) it is associated with low enzyme
CC       activity. Common genetic variation in UGT1A6 confers functionally
CC       significant differences in biochemical phenotype. This genetic
CC       variation might impact clinical efficacy or toxicity of drugs
CC       metabolized by UGT1A6. {ECO:0000269|PubMed:15284531,
CC       ECO:0000269|PubMed:9429234}.
CC   -!- MISCELLANEOUS: The gene is part of the UGT1A complex locus which
CC       displays alternative use of promoters, first exons and terminal
CC       exons. The locus is defined by 13 first exons, which are
CC       alternatively spliced to 3 other common exons and 2 alternative
CC       terminal exons 5. From the 27 possible mRNA isoforms, 9 produce
CC       functionally active polypeptides (UGT1A1, 1A3, 1A4, 1A5, 1A6, 1A7,
CC       1A8, 1A9 and 1A10) called isoforms 1 (i1). Use of an alternative
CC       exon 5 (5b) as terminal exon is leading to 9 additional
CC       alternatively spliced products termed isoforms i2 and which lack
CC       transferase activity.
CC   -!- SIMILARITY: Belongs to the UDP-glycosyltransferase family.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BM924331; Type=Erroneous termination; Positions=420; Note=Translated as Glu.; Evidence={ECO:0000305};
CC       Sequence=BM924331; Type=Frameshift; Positions=451, 463; Evidence={ECO:0000305};
CC       Sequence=BM924331; Type=Miscellaneous discrepancy; Note=Probable cloning artifact.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M84130; AAC41717.1; -; Genomic_DNA.
DR   EMBL; M84124; AAA61247.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; M84122; AAA61247.1; JOINED; Genomic_DNA.
DR   EMBL; M84123; AAA61247.1; JOINED; Genomic_DNA.
DR   EMBL; J04093; AAA61251.1; -; mRNA.
DR   EMBL; AF297093; AAG30420.1; -; Genomic_DNA.
DR   EMBL; DQ364250; ABC96774.1; -; mRNA.
DR   EMBL; AC006985; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC114812; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BM924331; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; AF014112; AAB87411.1; -; Genomic_DNA.
DR   CCDS; CCDS2507.1; -. [P19224-1]
DR   CCDS; CCDS2508.1; -. [P19224-2]
DR   PIR; A31340; A31340.
DR   RefSeq; NP_001063.2; NM_001072.3. [P19224-1]
DR   UniGene; Hs.554822; -.
DR   ProteinModelPortal; P19224; -.
DR   BioGrid; 120056; 1.
DR   IntAct; P19224; 7.
DR   STRING; 9606.ENSP00000303174; -.
DR   BindingDB; P19224; -.
DR   ChEMBL; CHEMBL1743316; -.
DR   DrugBank; DB00316; Acetaminophen.
DR   DrugBank; DB08826; Deferiprone.
DR   DrugBank; DB00688; Mycophenolate mofetil.
DR   DrugBank; DB01024; Mycophenolic acid.
DR   DrugBank; DB00818; Propofol.
DR   DrugBank; DB00197; Troglitazone.
DR   DrugBank; DB00313; Valproic Acid.
DR   CAZy; GT1; Glycosyltransferase Family 1.
DR   iPTMnet; P19224; -.
DR   PhosphoSitePlus; P19224; -.
DR   BioMuta; UGT1A6; -.
DR   DMDM; 29840832; -.
DR   EPD; P19224; -.
DR   PaxDb; P19224; -.
DR   PeptideAtlas; P19224; -.
DR   PRIDE; P19224; -.
DR   DNASU; 54578; -.
DR   Ensembl; ENST00000305139; ENSP00000303174; ENSG00000167165. [P19224-1]
DR   Ensembl; ENST00000373424; ENSP00000362523; ENSG00000167165. [P19224-2]
DR   GeneID; 54578; -.
DR   KEGG; hsa:54578; -.
DR   UCSC; uc002vuu.4; human. [P19224-1]
DR   CTD; 54578; -.
DR   DisGeNET; 54578; -.
DR   GeneCards; UGT1A6; -.
DR   HGNC; HGNC:12538; UGT1A6.
DR   HPA; CAB009819; -.
DR   HPA; HPA054065; -.
DR   MIM; 191740; gene.
DR   MIM; 606431; gene.
DR   neXtProt; NX_P19224; -.
DR   OpenTargets; ENSG00000167165; -.
DR   PharmGKB; PA37181; -.
DR   eggNOG; KOG1192; Eukaryota.
DR   eggNOG; COG1819; LUCA.
DR   GeneTree; ENSGT00760000118949; -.
DR   HOGENOM; HOG000220832; -.
DR   HOVERGEN; HBG004033; -.
DR   InParanoid; P19224; -.
DR   KO; K00699; -.
DR   OMA; MIVIDMY; -.
DR   OrthoDB; EOG091G06JC; -.
DR   PhylomeDB; P19224; -.
DR   TreeFam; TF315472; -.
DR   BRENDA; 2.4.1.17; 2681.
DR   Reactome; R-HSA-156588; Glucuronidation.
DR   SABIO-RK; P19224; -.
DR   GeneWiki; UGT1A6; -.
DR   GenomeRNAi; 54578; -.
DR   PRO; PR:P19224; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   Bgee; ENSG00000167165; -.
DR   ExpressionAtlas; P19224; baseline and differential.
DR   Genevisible; P19224; HS.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:UniProtKB.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; NAS:BHF-UCL.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0019899; F:enzyme binding; IPI:BHF-UCL.
DR   GO; GO:0015020; F:glucuronosyltransferase activity; IDA:UniProtKB.
DR   GO; GO:0046982; F:protein heterodimerization activity; IDA:UniProtKB.
DR   GO; GO:0042803; F:protein homodimerization activity; IDA:UniProtKB.
DR   GO; GO:0052695; P:cellular glucuronidation; IDA:UniProtKB.
DR   GO; GO:2001030; P:negative regulation of cellular glucuronidation; ISS:BHF-UCL.
DR   GO; GO:0045922; P:negative regulation of fatty acid metabolic process; ISS:BHF-UCL.
DR   GO; GO:1904224; P:negative regulation of glucuronosyltransferase activity; ISS:BHF-UCL.
DR   GO; GO:0052697; P:xenobiotic glucuronidation; IBA:GO_Central.
DR   GO; GO:0006805; P:xenobiotic metabolic process; IDA:UniProtKB.
DR   InterPro; IPR002213; UDP_glucos_trans.
DR   PANTHER; PTHR11926; PTHR11926; 1.
DR   Pfam; PF00201; UDPGT; 1.
DR   PROSITE; PS00375; UDPGT; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Complete proteome; Endoplasmic reticulum;
KW   Glycoprotein; Glycosyltransferase; Membrane; Microsome; Polymorphism;
KW   Reference proteome; Signal; Transferase; Transmembrane;
KW   Transmembrane helix.
FT   SIGNAL        1     26       {ECO:0000255}.
FT   CHAIN        27    532       UDP-glucuronosyltransferase 1-6.
FT                                /FTId=PRO_0000036005.
FT   TRANSMEM    490    506       Helical. {ECO:0000255}.
FT   CARBOHYD    294    294       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    346    346       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   VAR_SEQ       1    267       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_045779.
FT   VAR_SEQ     434    532       SYKENIMRLSSLHKDRPVEPLDLAVFWVEFVMRHKGAPHLR
FT                                PAAHDLTWYQYHSLDVIGFLLAVVLTVAFITFKCCAYGYRK
FT                                CLGKKGRVKKAHKSKTH -> RKKQQSGRQM (in
FT                                isoform 3). {ECO:0000303|Ref.4}.
FT                                /FTId=VSP_053962.
FT   VARIANT       7      7       S -> A (in allele UGT1A6*2, allele
FT                                UGT1A6*3 and allele UGT1A6*4;
FT                                dbSNP:rs6759892).
FT                                {ECO:0000269|PubMed:15284531}.
FT                                /FTId=VAR_024685.
FT   VARIANT      70     70       S -> Y (in dbSNP:rs1042708).
FT                                {ECO:0000269|PubMed:1339448}.
FT                                /FTId=VAR_026628.
FT   VARIANT     181    181       T -> A (in allele UGT1A6*2;
FT                                dbSNP:rs2070959).
FT                                {ECO:0000269|PubMed:15284531,
FT                                ECO:0000269|PubMed:19204906,
FT                                ECO:0000269|PubMed:9429234,
FT                                ECO:0000269|Ref.4}.
FT                                /FTId=VAR_014784.
FT   VARIANT     184    184       R -> S (in allele UGT1A6*2 and allele
FT                                UGT1A6*4; dbSNP:rs1105879).
FT                                {ECO:0000269|PubMed:15284531,
FT                                ECO:0000269|PubMed:19204906,
FT                                ECO:0000269|PubMed:9429234,
FT                                ECO:0000269|Ref.4}.
FT                                /FTId=VAR_015559.
FT   VARIANT     510    510       A -> P (in dbSNP:rs1042709).
FT                                {ECO:0000269|PubMed:1339448}.
FT                                /FTId=VAR_026629.
FT   CONFLICT    231    231       E -> K (in Ref. 1; AAA61251).
FT                                {ECO:0000305}.
FT   CONFLICT    247    249       YQK -> SE (in Ref. 1; AAA61251).
FT                                {ECO:0000305}.
FT   CONFLICT    328    328       I -> N (in Ref. 1; AAA61251).
FT                                {ECO:0000305}.
FT   CONFLICT    419    419       S -> F (in Ref. 6; BM924331).
FT                                {ECO:0000305}.
FT   CONFLICT    446    446       H -> S (in Ref. 6; BM924331).
FT                                {ECO:0000305}.
FT   CONFLICT    468    468       K -> Q (in Ref. 6; BM924331).
FT                                {ECO:0000305}.
FT   CONFLICT    476    477       AA -> GS (in Ref. 6; BM924331).
FT                                {ECO:0000305}.
FT   CONFLICT    514    514       R -> P (in Ref. 1; AAA61251).
FT                                {ECO:0000305}.
SQ   SEQUENCE   532 AA;  60751 MW;  4A9EA6A88CBC3136 CRC64;
     MACLLRSFQR ISAGVFFLAL WGMVVGDKLL VVPQDGSHWL SMKDIVEVLS DRGHEIVVVV
     PEVNLLLKES KYYTRKIYPV PYDQEELKNR YQSFGNNHFA ERSFLTAPQT EYRNNMIVIG
     LYFINCQSLL QDRDTLNFFK ESKFDALFTD PALPCGVILA EYLGLPSVYL FRGFPCSLEH
     TFSRSPDPVS YIPRCYTKFS DHMTFSQRVA NFLVNLLEPY LFYCLFSKYE ELASAVLKRD
     VDIITLYQKV SVWLLRYDFV LEYPRPVMPN MVFIGGINCK KRKDLSQEFE AYINASGEHG
     IVVFSLGSMV SEIPEKKAMA IADALGKIPQ TVLWRYTGTR PSNLANNTIL VKWLPQNDLL
     GHPMTRAFIT HAGSHGVYES ICNGVPMVMM PLFGDQMDNA KRMETKGAGV TLNVLEMTSE
     DLENALKAVI NDKSYKENIM RLSSLHKDRP VEPLDLAVFW VEFVMRHKGA PHLRPAAHDL
     TWYQYHSLDV IGFLLAVVLT VAFITFKCCA YGYRKCLGKK GRVKKAHKSK TH
//
